254 related articles for article (PubMed ID: 34111554)
1. Safety of Direct Oral Anticoagulants Compared to Warfarin for Atrial Fibrillation after Cardiac Surgery: A Systematic Review and Meta-Analysis.
Hage A; Dolan DP; Nasr VG; Castelo-Branco L; Motta-Calderon D; Ghandour H; Hage F; Papatheodorou S; Chu MWA
Semin Thorac Cardiovasc Surg; 2022; 34(3):947-957. PubMed ID: 34111554
[TBL] [Abstract][Full Text] [Related]
2. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
[TBL] [Abstract][Full Text] [Related]
3. Direct oral anticoagulants in atrial fibrillation following cardiac surgery: a systematic review and meta-analysis with trial sequential analysis.
Koh KK; Ling RR; Tan SYS; Chen Y; Fan BE; Shekar K; Sule JA; Subbian SK; Ramanathan K
Br J Anaesth; 2022 Aug; 129(2):154-162. PubMed ID: 35729010
[TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
López-López JA; Sterne JAC; Thom HHZ; Higgins JPT; Hingorani AD; Okoli GN; Davies PA; Bodalia PN; Bryden PA; Welton NJ; Hollingworth W; Caldwell DM; Savović J; Dias S; Salisbury C; Eaton D; Stephens-Boal A; Sofat R
BMJ; 2017 Nov; 359():j5058. PubMed ID: 29183961
[No Abstract] [Full Text] [Related]
5. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A;
CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273
[TBL] [Abstract][Full Text] [Related]
6. Novel oral anticoagulants in atrial fibrillation: a meta-analysis of large, randomized, controlled trials vs warfarin.
Dogliotti A; Paolasso E; Giugliano RP
Clin Cardiol; 2013 Feb; 36(2):61-7. PubMed ID: 23338902
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic Review and Meta-analysis.
Elshafei MN; El-Bardissy A; Salem M; Abdelmoneim MS; Khalil A; Elhadad S; Danjuma M
Am J Cardiovasc Drugs; 2024 Mar; 24(2):255-271. PubMed ID: 38386247
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Direct Oral Anticoagulants (DOACs) Versus Warfarin in Atrial Fibrillation Patients with Prior Stroke: a Systematic Review and Meta-analysis.
Umashankar K; Mammi M; Badawoud E; Tang Y; Zhou M; Borges JC; Liew A; Migliore M; Mekary RA
Cardiovasc Drugs Ther; 2023 Dec; 37(6):1225-1237. PubMed ID: 35467313
[TBL] [Abstract][Full Text] [Related]
10. Impact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation.
Harskamp RE; Teichert M; Lucassen WAM; van Weert HCPM; Lopes RD
Cardiovasc Drugs Ther; 2019 Oct; 33(5):615-623. PubMed ID: 31520256
[TBL] [Abstract][Full Text] [Related]
11. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
12. Comparing mortality in patients with atrial fibrillation who are receiving a direct-acting oral anticoagulant or warfarin: a meta-analysis of randomized trials.
Liew A; O'Donnell M; Douketis J
J Thromb Haemost; 2014 Sep; 12(9):1419-24. PubMed ID: 24986568
[TBL] [Abstract][Full Text] [Related]
13. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
Ruff CT; Giugliano RP; Braunwald E; Hoffman EB; Deenadayalu N; Ezekowitz MD; Camm AJ; Weitz JI; Lewis BS; Parkhomenko A; Yamashita T; Antman EM
Lancet; 2014 Mar; 383(9921):955-62. PubMed ID: 24315724
[TBL] [Abstract][Full Text] [Related]
15. Fracture risks in patients with atrial fibrillation treated with different oral anticoagulants: a meta-analysis and systematic review.
Xie X; Liu Y; Li J; Gu F; Zhang K; Sui Z; Zhang J; Yu T
Age Ageing; 2022 Jan; 51(1):. PubMed ID: 35077554
[TBL] [Abstract][Full Text] [Related]
16. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis.
Gupta S; Um KJ; Pandey A; McIntyre WF; Ivanova M; Allahverdi Y; Agahi P; Pandya F; Lopez A; Sachdeva A; Whitlock RP; Belley-Cote EP
Cardiovasc Drugs Ther; 2019 Jun; 33(3):339-352. PubMed ID: 31011880
[TBL] [Abstract][Full Text] [Related]
17. Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data.
Hu W; Cai H; Zhang J
Eur J Clin Pharmacol; 2022 Jul; 78(7):1057-1067. PubMed ID: 35296907
[TBL] [Abstract][Full Text] [Related]
18. Direct Oral Anticoagulant Versus Warfarin After Left Atrial Appendage Closure With WATCHMAN: Updated Systematic Review and Meta-analysis.
Tan BE; Wong PY; Lee JZ; Tan NY; Rao M; Cheung JW
Curr Probl Cardiol; 2022 Nov; 47(11):101335. PubMed ID: 35872052
[TBL] [Abstract][Full Text] [Related]
19. Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
Jackevicius CA; Lu L; Ghaznavi Z; Warner AL
Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007230. PubMed ID: 33541109
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.
Miller CS; Grandi SM; Shimony A; Filion KB; Eisenberg MJ
Am J Cardiol; 2012 Aug; 110(3):453-60. PubMed ID: 22537354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
